Crypto Market Cap$2,111,471,977,9433.07%
Staking Market Cap$633,558,222,4187.47%
Locked in Staking$146,523,582,3205.7%
Proof of Stake Dominance58.68%1.36%
Average Reward Rate14.95%-1.07%
Average Total Staked23.13%-1.65%
Crypto Market Cap$2,111,471,977,9433.07%
Staking Market Cap$633,558,222,4187.47%
Locked in Staking$146,523,582,3205.7%
Proof of Stake Dominance58.68%1.36%
Average Reward Rate14.95%-1.07%
Average Total Staked23.13%-1.65%
#201
On 11 watchlists

Injective Protocol

INJ

About

Injective Protocol is a decentralized derivatives trading protocol.

$337,335,338

7d
30d
90d

+12.68%

$15.29

Reward Options
Risk
Complexity
Reward
Adj. Reward
Minimum
Lock Up
Avg. Fee
Participating
Stake INJ on Testnet
Risk
stable
Complexity
moderate
Reward
17%
Minimum
-
Lock Up
-
Participating
-
Adj. Reward
-
Avg. Fee
-

Advanced calculator

Revenue over time (USD / week)

Total Reward Rate

0%

or 0% annualized

Est. Monthly Earning

$0

0 INJ

Est. Yearly Earning

$0

0 INJ

FAQ's

  • How to Stake INJ?

    Equinox Staking is now live!

    This will serve as the final phase of the Injective Protocol testnet before mainnet launch.

    Equinox Staking will allow both validators and delegators to stake on Injective as they prepare to launch the mainnet in Q2. This will also mark the first time that users and community members will be able to earn rewards by actively staking INJ.

    To start staking, please go HERE.

  • How much can I earn Staking INJ?

    Currently with Equinox Staking you can earn up to 17% in annual returns.

    The testnet reward rate is being derived from a baseline APY of 3% with boost APY coming from Claim Reward (0.5%), Propose Market Reward (3%), Re-delegate Reward (0.5%), Governance Reward (2%), Propose Market Successfully Reward (5%), and Epic Reward (3%).

    Check out the Injective Protocol Staking Rewards Calculator to estimate your INJ staking returns.

  • Is there any risks to Staking INJ?

    Please note that this Equinox Staking is the final phase of the Injective Protocol testnet and should be considered a moderate risk.

Last updated: 2021-05-17 17:59:36